Informed consent is more than a signature – it's a promise of understanding. At RWS, we help clinical trial sponsors and CROs transform complex, technical documents into clear, accessible, and culturally appropriate materials that empower participants to make truly informed decisions.
Whether you're navigating global regulations, translating into multiple languages, or striving to meet plain language standards, RWS is your trusted partner. Our expert linguists, medical writers, and regulatory specialists work together to ensure your informed consent forms (ICFs) are accurate, compliant, and participant-friendly – every time.
Free resources to support your ICF strategy
We’re offering three essential resources to help you create better informed consent experiences. Download them now to learn how to simplify your content, engage participants, and stay ahead of evolving regulations.
Informed eConsent Forms – Revolutionizing Clinical Trial Administration
- The role of AI in eConsent and translation
- Enhancing patient engagement through plain language
- Meeting EU and FDA expectations for lay summaries
- Building inclusive, multilingual consent strategies


The RWS Toolkit for Easy ICFs
This hands-on toolkit is packed with best practices for writing, formatting, and translating ICFs. It includes checklists, layout tips, terminology guidance, and translation quality controls—all designed to help you simplify your documents without sacrificing accuracy.
What you’ll find inside:
- Plain language principles and readability tips
- Layout and formatting do’s and don’ts
- Terminology simplification strategies
- A comprehensive translation checklist
- How RWS supports every step of the ICF lifecycle
Plain Language, Global Impact
This thought leadership piece explores the growing importance of Plain Language Summaries (PLS) in clinical research. It outlines how RWS helps sponsors meet regulatory requirements while building trust and transparency with patients through clear, culturally adapted communication.
Highlights include:
- Why plain language is now a regulatory and ethical imperative
- How to balance clarity with scientific accuracy
- The challenges of multilingual PLS and how RWS solves them
- The role of patient feedback in improving comprehension

Why RWS?
- 98% translation accuracy
- 99% on-time delivery
- Trusted by 9/10 top CROs and 19/20 top pharma companies
- ISO-certified and ICH-GCP trained
- 30+ years of life sciences experience
- 60+ global locations
Ready to take your informed consent strategy to the next level?
Our team of ICF and plain language experts is here to understand your challenges, answer your questions, and help you launch a safe and successful clinical trial.